LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2026). Frontier in Medical and Health Research, 4(3), 3196-3217. https://fmhr.net/index.php/fmhr/article/view/3537